Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: ASHS provides Gamma Knife radiosurgery units and radiation therapy equipment to medical centers. As of September 30, 2008, the company operated 19 Gamma Knife units across 19 medical centers. The company also holds a significant investment in Still River Systems, Inc., a development-stage company creating proton beam radiation therapy (PBRT) systems.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2008 | Nine Months Ended Sep 30, 2008 | Balance Sheet (Sep 30, 2008) |
|---|---|---|---|
| Revenue | $4,532,000 | $14,359,000 | N/A |
| Gross Margin | $1,884,000 (41.6%) | $6,296,000 (43.8%) | N/A |
| Operating Income | $130,000 | $1,111,000 | N/A |
| Net Income | $25,000 | $394,000 | N/A |
| Earnings Per Share (Diluted) | $0.00 | $0.08 | N/A |
| Cash and Equivalents | N/A | N/A | $8,788,000 |
| Total Assets | N/A | N/A | $63,009,000 |
| Total Debt (Current + Long-term) | N/A | N/A | $26,205,000 |
| Working Capital | N/A | N/A | ($247,000) Deficit |
Material Changes vs. Prior Period
- Revenue: Revenue decreased 2.6% for the three-month period ($4.53M vs. $4.65M) due to the loss of three Gamma Knife contracts. However, revenue increased 0.3% for the nine-month period ($14.36M vs. $14.31M) driven by a 7% increase at existing sites and new radiation therapy contracts.
- Profitability: Net income declined significantly, dropping 90.7% for the quarter ($25k vs. $268k) and 49.0% for the nine-month period ($394k vs. $773k). This was primarily driven by higher depreciation and interest expenses associated with new equipment upgrades.
- Costs: Total costs of revenue increased due to higher depreciation on four new Perfexion units and a new radiation therapy site. Interest expense rose 47% for the quarter and 34% for the nine-month period due to term financing for equipment upgrades.
- Procedures: The number of Gamma Knife procedures decreased by 25% for the quarter (432 vs. 575) and 22% for the nine-month period (1,410 vs. 1,803), reflecting contract terminations and equipment downtime for upgrades.
Guidance, Outlook, and Risks
- Liquidity: The company reported a working capital deficit of $247,000 but maintains $8.8M in cash. Management believes cash flow from operations is adequate to meet scheduled debt obligations of approximately $10.3M and capital lease payments of $1.8M over the next 12 months.
- Investment Risks: ASHS holds a $2.6M investment in Still River Systems, Inc., a development-stage company. The PBRT systems are not yet FDA approved, and Still River requires additional capital. Management monitors this investment quarterly for impairment.
- Capital Commitments: The company has approximately $21.8M in remaining commitments to purchase equipment, including two Monarch 250 PBRT systems and Gamma Knife upgrades. Financing for these commitments is not guaranteed.
- Subsequent Event: On October 10, 2008, ASHS entered into a non-binding agreement to provide a PBRT system to Long Beach Memorial Medical Center, with a $250,000 refundable deposit.
Investor Verification Checklist
- Contract Renewals: Verify the status of the three terminated Gamma Knife contracts and the timeline for securing new customers to offset lost revenue.
- Still River Viability: Assess the progress of Still River Systems toward FDA approval and their ability to secure necessary funding, given the $2.6M exposure.
- Debt Servicing: Confirm the company's ability to service $12.1M in debt and lease obligations due within 12 months despite the working capital deficit.
- Equipment Financing: Monitor the company's ability to secure financing for the $21.8M in outstanding equipment purchase commitments.
- Procedure Volume: Track the recovery of procedure volumes at existing sites following the recent upgrades and downtime.